121 related articles for article (PubMed ID: 25096509)
1. Role of the functional variant (-652T>G) in the XRCC4 promoter in prostate cancer.
Shao N; Li J; Xu B; Wang Y; Lu X; Feng N
Mol Biol Rep; 2014 Nov; 41(11):7463-70. PubMed ID: 25096509
[TBL] [Abstract][Full Text] [Related]
2. Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.
Shao N; Wang Y; Lu K; Jiang WY; Li Q; Wang N; Feng NH; Hua LX
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1531-9. PubMed ID: 22526163
[TBL] [Abstract][Full Text] [Related]
3. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Chang CL; Tsai CW; Wu HC; Chiu CF; Wang RF; Liu CS; Lin CC; Bau DT
Anticancer Res; 2009 May; 29(5):1777-82. PubMed ID: 19443403
[TBL] [Abstract][Full Text] [Related]
4. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.
Huang Q; Whitington T; Gao P; Lindberg JF; Yang Y; Sun J; Väisänen MR; Szulkin R; Annala M; Yan J; Egevad LA; Zhang K; Lin R; Jolma A; Nykter M; Manninen A; Wiklund F; Vaarala MH; Visakorpi T; Xu J; Taipale J; Wei GH
Nat Genet; 2014 Feb; 46(2):126-35. PubMed ID: 24390282
[TBL] [Abstract][Full Text] [Related]
5. Genotypic analysis of
Gupta MK; Kushwah AS; Singh R; Banerjee M
Br J Biomed Sci; 2020 Jan; 77(1):7-12. PubMed ID: 31250713
[No Abstract] [Full Text] [Related]
6. Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.
Wu KH; Wang CH; Yang YL; Peng CT; Lin WD; Tsai FJ; Lin DT; Bau DT
Anticancer Res; 2010 Feb; 30(2):529-33. PubMed ID: 20332465
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan.
Hsu NY; Wang HC; Wang CH; Chang CL; Chiu CF; Lee HZ; Tsai CW; Bau DT
Cancer Biomark; 2009; 5(4):159-65. PubMed ID: 19729825
[TBL] [Abstract][Full Text] [Related]
8. XRCC4 codon 247*A and XRCC4 promoter -1394*T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis.
Hsieh YY; Bau DT; Chang CC; Tsai CH; Chen CP; Tsai FJ
Mol Reprod Dev; 2008 May; 75(5):946-51. PubMed ID: 18246529
[TBL] [Abstract][Full Text] [Related]
9. A rare variant in the osteoarthritis-associated locus GDF5 is functional and reveals a site that can be manipulated to modulate GDF5 expression.
Dodd AW; Syddall CM; Loughlin J
Eur J Hum Genet; 2013 May; 21(5):517-21. PubMed ID: 22929025
[TBL] [Abstract][Full Text] [Related]
10. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Shin S; Oh S; An S; Janknecht R
Oncol Rep; 2013 Jan; 29(1):306-14. PubMed ID: 23076342
[TBL] [Abstract][Full Text] [Related]
11. Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.
Shin T; Sumiyoshi H; Matsuo N; Satoh F; Nomura Y; Mimata H; Yoshioka H
Arch Biochem Biophys; 2005 Mar; 435(2):291-302. PubMed ID: 15708372
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan.
Bau DT; Yang MD; Tsou YA; Lin SS; Wu CN; Hsieh HH; Wang RF; Tsai CW; Chang WS; Hsieh HM; Sun SS; Tsai RY
Anticancer Res; 2010 Jul; 30(7):2727-30. PubMed ID: 20683005
[TBL] [Abstract][Full Text] [Related]
13. SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers.
Okamoto K; Tsunematsu R; Tahira T; Sonoda K; Asanoma K; Yagi H; Yoneda T; Hayashi K; Wake N; Kato K
BMC Med Genet; 2015 Aug; 16():67. PubMed ID: 26293665
[TBL] [Abstract][Full Text] [Related]
14. An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.
Yu H; Zhao H; Wang LE; Han Y; Chen WV; Amos CI; Rafnar T; Sulem P; Stefansson K; Landi MT; Caporaso N; Albanes D; Thun M; McKay JD; Brennan P; Wang Y; Houlston RS; Spitz MR; Wei Q
DNA Repair (Amst); 2011 Apr; 10(4):398-407. PubMed ID: 21296624
[TBL] [Abstract][Full Text] [Related]
15. Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.
Zhang H; Gelernter J; Gruen JR; Kranzler HR; Herman AI; Simen AA
J Hum Genet; 2010 May; 55(5):278-84. PubMed ID: 20300121
[TBL] [Abstract][Full Text] [Related]
16. A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer.
Wang M; Wang M; Yuan L; Wu D; Zhang Z; Yin C; Fu G; Wei Q; Zhang Z
Oncogene; 2010 Apr; 29(13):1920-8. PubMed ID: 20062074
[TBL] [Abstract][Full Text] [Related]
17. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
19. An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies.
Shao N; Jiang WY; Qiao D; Zhang SG; Wu Y; Zhang XX; Hua LX; Ding Y; Feng NH
Cancer Biomark; 2012-2013; 12(1):37-47. PubMed ID: 23321468
[TBL] [Abstract][Full Text] [Related]
20. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
